Get Free Sample link @ https://www.omrglobal.com/request-sample/neuropathic-pain-treatment-market
Since 2015-2018/2019, motor vehicle accidents are the major cause of spinal cord injuries (39.3%), which is followed by falls (31.8%), acts of violence (13.5%), sports (8%), medical/surgical (4.3%), and other (3.1%). Nearly 2/3rd of sports injuries were reported from diving. People with spinal cord injury may suffer from different kinds of pain in different areas of the body, which comprises musculoskeletal pain, visceral pain, and neuropathic pain. Spinal cord injury results in damage to any part of the nerves or spinal that causes abnormal communication between the nerves, which results in neuropathic pain. This contributes to the increasing demand for medications to treat neuropathic pain.
A full report of Global Neuropathic Pain Treatment Market available @ https://www.omrglobal.com/industry-reports/neuropathic-pain-treatment-market
• Market Coverage
• Market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered- By Source, By Product Type, By Applications
• Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Neuropathic Pain Treatment Market by Indication
o Spinal Stenosis
o Diabetic Neuropathy
o Chemotherapy-Induced Peripheral Neuropathy
o Others
Global Neuropathic Pain Treatment Market by Treatment
o Tricyclic Antidepressants
o Anticonvulsants
o Opioids
o Creams and Patches
o Steroids
o Others (Neurostimulation and Local Anesthesia)
Regional Analysis
o North America
o United States
o Canada
o Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe
o Asia-Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
o Rest of the World
Company Profiles
o Abbott Laboratories
o Acorda Therapeutics, Inc.
o Assertio Therapeutics, Inc.
o Astellas Pharma Inc.
o AstraZeneca plc
o Biogen Inc.
o BioIntervene, Inc.
o Boston Scientific Corp.
o Cipla Ltd.
o Dr. Reddy’s Laboratories Ltd.
o Eli Lilly and Co.
o GlaxoSmithKline plc
o Glenmark Pharmaceuticals Ltd.
o Grünenthal GmbH
o Johnson & Johnson Services, Inc.
o Lexicon Pharmaceuticals, Inc.
o Lupin Ltd.
o Medtronic plc
o Pfizer Inc.
o Sanofi S.A.
o Teva Pharmaceutical Industries Ltd.
The Report Covers
• Market value data analysis of 2019 and forecast to 2026.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global neuropathic pain treatment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/neuropathic-pain-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404